BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3051271)

  • 1. [Medical disability expertise in systemic scleroderma].
    Shabel'nik VI; Tsyban' ME; Filiuk VF; Eliseĭkina LV; Lanchuk SG
    Revmatologiia (Mosk); 1988; (2):23-6. PubMed ID: 3051271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of the state of the cardiovascular system in the disability evaluation of patients with systemic lupus erythematosus and scleroderma].
    Zhabina TN; Morozova RZ; Otkalenko IuK
    Vrach Delo; 1977 Nov; (11):72-5. PubMed ID: 595566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of work capacity of patients with systemic lupus erythematosus and systemic scleroderma].
    Timeskov IS; Chirkina SS; Dolgobvorova KF; Gil'fanov RN; Zhuravleva SI
    Ter Arkh; 1979; 51(1):68-71. PubMed ID: 432836
    [No Abstract]   [Full Text] [Related]  

  • 4. [The evolution of the concepts of systemic scleroderma].
    Guseva NG
    Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781
    [No Abstract]   [Full Text] [Related]  

  • 5. Validity of the scleroderma functional assessment questionnaire.
    Poole JL; Brower L
    J Rheumatol; 2004 Feb; 31(2):402-3. PubMed ID: 14760822
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological age in patients with progressive scleroderma].
    Sauer I; Ries W; Mittag M; Haustein UF
    Z Gerontol Geriatr; 1996; 29(3):223-32. PubMed ID: 8767020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Work capacity assessment of systemic lupus erythematosus patients during the initial examination at the Medical Commission for Determination of Disability].
    Tarasov AN; Chirkina SS; Afanas'eva IK; Dolgodvorova KF; Prudnikov AM
    Ter Arkh; 1984; 56(5):36-9. PubMed ID: 6463884
    [No Abstract]   [Full Text] [Related]  

  • 8. [Survival and prognostic significance of a kidney lesion in systemic scleroderma].
    Guseva NG; Anikina NV; Balabanova RM
    Ter Arkh; 1982; 54(7):99-102. PubMed ID: 7135234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scleroatrophic lichen and its relation to scleroderma].
    Kalamkarian AA; Fedorova EG
    Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014
    [No Abstract]   [Full Text] [Related]  

  • 10. [The evolution of juvenile systemic scleroderma].
    Starovoĭtova MN; Guseva NG
    Ter Arkh; 1997; 69(11):55-60. PubMed ID: 9483750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Work disability expertise on persons with a single kidney and certain urological diseases].
    Orlov AP; Trapenznikova MF; Mal'tseva LM; Melamed SB
    Urol Nefrol (Mosk); 1973; 38(2):10-4. PubMed ID: 4756555
    [No Abstract]   [Full Text] [Related]  

  • 12. A cross-sectional comparison of three self-reported functional indices in scleroderma.
    Smyth AE; MacGregor AJ; Mukerjee D; Brough GM; Black CM; Denton CP
    Rheumatology (Oxford); 2003 Jun; 42(6):732-8. PubMed ID: 12730528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the burden of scleroderma disease in Spain.
    Villaverde-Hueso A; Sánchez-Valle E; Alvarez E; Morant C; Carreira PE; Martín-Arribas MC; Gènova R; Ramírez-González A; de la Paz MP
    J Rheumatol; 2007 Nov; 34(11):2236-42. PubMed ID: 17918783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Visceral lesions in systemic scleroderma].
    Shub NI
    Vrach Delo; 1973 May; 5():39-42. PubMed ID: 4757731
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.
    Kuwana M; Sato S; Kikuchi K; Kawaguchi Y; Fujisaku A; Misaki Y; Hatamochi A; Kondo H; Takehara K
    J Rheumatol; 2003 Jun; 30(6):1253-8. PubMed ID: 12784399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
    Malcarne VL; Hansdottir I; McKinney A; Upchurch R; Greenbergs HL; Henstorf GH; Furst DE; Clements PJ; Weisman MH
    J Rheumatol; 2007 Feb; 34(2):359-67. PubMed ID: 17304659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of a combination of systemic scleroderma with diffuse eosinophilic fasciitis].
    Krasovskiĭ II; Shkodkin IV; Vladimirova NN
    Ter Arkh; 1996; 68(9):84-5. PubMed ID: 9005625
    [No Abstract]   [Full Text] [Related]  

  • 19. Using a self-reported functional score to assess disease progression in systemic sclerosis.
    Serednicka K; Smyth AE; Black CM; Denton CP
    Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of systemic scleroderma].
    Guĭda PP
    Klin Med (Mosk); 1983 Jun; 61(6):82-5. PubMed ID: 6887774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.